Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (vol 396, pg 467, 2020)

Folegatti PM., Ewer KJ., Aley PK., Angus B., Becker S., Belij-Rammerstorfer S., Bellamy D., Bibi S., Bittaye M., Clutterbuck EA., Dold C., Faust SN., Finn A., Flaxman AL., Hallis B., Heath P., Jenkin D., Lazarus R., Makinson R., Minassian AM., Pollock KM., Ramasamy M., Robinson H., Snape M., Tarrant R., Voysey M., Green C., Douglas AD., Hill AVS., Lambe T., Gilbert SC., Pollard AJ., Grp OCOVIDVT.

Type

Journal article

Journal

LANCET

Publication Date

15/08/2020

Volume

396

Pages

466 - 466

Permalink